Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform
Recruiting now · Not applicable
Conditions studied: Lung Cancer
In brief
This study focuses on the significant impact of lung cancer in China, highlighted by its high incidence and mortality rates, influenced by factors like aging populations, smoking, and environmental issues. It emphasizes the importance of understanding the duration, severity, and factors affecting post-surgery symptoms like pain and coughing in patients. The research underlines the value of patient-reported outcomes (PROs) in enhancing postoperative care and survival rates through improved symptom monitoring and patient engagement. Utilizing internet technology, specifically a platform integrated with WeChat, the study aims to improve patient management and follow-ups post-discharge. The objective is to use mobile internet technology to build a high-quality prospective database on postoperative lung cancer patient outcomes, analyzing factors affecting postoperative discomfort and assessing the role of interactive platforms in improving patient care.
Key facts
- Study ID
- NCT06483295
- Run by
- Shanghai Chest Hospital
- People needed
- 216
- Starts
- 2024-03-24
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2025-05-28
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Diagnosed with Stage I-III lung cancer and surgically resected at our centre.
- Owns and uses a smartphone and can use WeChat.
- Volunteer to participate in this study and sign an informed consent form.
You may not qualify if…
- Received any non-surgical anti-tumour therapy (radiotherapy, chemotherapy, targeted therapy or immunotherapy) for lung cancer during the follow-up period.
- After enrolment, preoperative emergence of serious comorbidities (inability to tolerate surgery or anaesthesia) that are not suitable for, or cannot be implemented as planned, in the study's treatment regimen.
- After admission, the patient's condition changes and the need to change from elective surgery to emergency surgery is confirmed by the doctor in charge.
- At any stage after entering the study, the patient voluntarily requests to withdraw or discontinue treatment due to personal reasons.
Where it is running
- Zuodong Song — Shanghai, Shanghai Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.